OLMAOlema Pharmaceuticals, Inc.
10.69USD-5.48%Mkt Cap: 935.35M $P/E: —3d ago
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. The company's lead product candidate is palazestrant…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap935.35M $
Enterprise Value496.31M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-162.45M $
Revenue/Share—
Last Price10.69 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees150
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.05
PEG—
EV/EBITDA-2.25
EV/Revenue—
P/S—
P/B2.21
EPS (TTM)-2.04
EPS (Forward)-2.69
52W Range
5.34017% of range36.26
52W High36.26 USD
52W Low5.340 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-33.95%
ROA-30.45%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-146.72M $
CapEx (TTM)—
FCF Margin—
FCF Yield-9.52%
Net Debt-457.41M $
Net Debt/EBITDA2.07
Balance Sheet
Debt/Equity0.01
Current Ratio8.86
Quick Ratio8.76
Book Value/Sh4.923 USD
Cash/Share5.270 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)39.30 USD
Upside (mean)+267.6%
Target Range20.00 USD – 59.00 USD
$20.00+267.6% to mean$59.00
# Analysts10
Ownership
Shares Out.87.50M
Float59.24M
Insiders1.76%
Institutions119.64%
Short Interest
Short Ratio13.8d
Short % Float22.17%
Short % Out.18.25%
Shares Short15.96M
Short (prev mo.)14.03M
Technical
SMA 5011.27 (-5.1%)
SMA 20017.61 (-39.3%)
Beta2.01
S&P 52W Chg18.16%
Avg Vol (30d)984.59K
Avg Vol (10d)1.24M
Technical Indicators
RSI (14)43.2
MACD-0.2336
MACD Signal-0.1709
MACD Hist.-0.0626
BB Upper12.46 USD
BB Middle11.34 USD
BB Lower10.21 USD
BB Width19.79%
ATR (14)0.6572 USD
Vol Ratio (20d)0.72x